The pharma company currently trades at a CMP of Rs 1,660, with a target price of Rs 2,100, representing a potential upside of 39% over a 12-month time frame. Aurobindo Pharma’s long-term chart shows a breakout above a prolonged consolidation range, followed by a retest of the breakout zone around Rs 1,000–1,100. The subsequent rebound suggests that the former resistance zone is acting as support, strengthening the case for a continuation of the broader uptrend.
State-owned defence major trades at a CMP of Rs 4,870 and has a target price of Rs 5,850, offering a potential upside of 25% over a 12-month time frame. On the monthly chart, HAL has consolidated within a contracting range following a strong uptrend, forming a symmetrical triangle. The price has recently moved above the descending trendline, suggesting a potential resumption of the broader uptrend.
The company has a CMP of Rs 185 and a target price of Rs 235, which reflects a potential upside of 45% over a 12-month time frame. On the six-monthly chart, IOLCP appears to be emerging from a prolonged consolidation that followed a strong advance. The recent move above the upper boundary of this range suggests a potential resumption of the broader uptrend.
The share price currently trades at a CMP of Rs 957, with a target price set at Rs 1,255, implying a potential upside of 48% over a 12-month time frame. On the quarterly chart, Jyoti CNC Automation Limited has broken above the upper boundary of a descending channel, signalling a potential improvement in its broader price structure.
The private lender trades at a CMP of Rs 306 and carries a target price of Rs 395, offering a potential upside of 45% over a 12-month time frame. On the long-term chart, the stock has broken out of a prolonged sideways consolidation and subsequently tested the breakout zone over three consecutive candles.